Skip to main content
KYORIN Pharmaceutical Co., Ltd. logo

KYORIN Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 4569 ISIN · JP3247090008 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2022-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4569

About KYORIN Pharmaceutical Co., Ltd.

https://www.kyorin-pharm.co.jp/en/

KYORIN Pharmaceutical Co., Ltd. is a research-based pharmaceutical company engaged in the research, development, manufacturing, and sale of prescription (ethical) and generic drugs. The company's commercial and R&D activities are focused on key therapeutic areas, including respiratory medicine, urology, otolaryngology (ENT), and inflammatory bowel disease (IBD). Through its subsidiaries, such as KYORIN Rimedio Co., Ltd., it also handles the manufacturing and distribution of generic medicines. The company is committed to providing a stable supply of high-quality pharmaceutical products to medical institutions and patients.

Recent filings

Filing Released Lang Actions
四半期報告書－第64期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Kyorin Holdings, Inc., covering the third quarter of the fiscal year ending March 31, 2022. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management's analysis of financial results. This fits the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese
四半期報告書－第64期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the second quarter of the fiscal year ending March 31, 2022. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2022
2021-11-12 Japanese
四半期報告書－第64期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Kyorin Holdings, Inc. covering the first quarter of the 64th fiscal year (April 1, 2021, to June 30, 2021). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management's analysis of financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2021-08-10 Japanese
内部統制報告書－第63期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. This type of report is a mandatory regulatory filing that assesses the effectiveness of a company's internal controls over financial reporting. Since it is a specific regulatory requirement distinct from a full Annual Report (10-K) or a simple announcement, and it does not fit into other categories like M&A or dividends, it is best classified as a Regulatory Filing (RNS).
2021-06-21 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2021
2021-06-21 Japanese
有価証券報告書－第63期(令和2年4月1日－令和3年3月31日)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, including consolidated financial indicators, balance sheets, and income statements for the fiscal year ending March 31, 2021. The document header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act. FY 2021
2021-06-21 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.